Utility of KRAS mutational analysis in the preoperative diagnosis of synchronous pancreatic cancer and intrahepatic cholangiocarcinoma: A case report.

about

Utility of KRAS mutational analysis in the preoperative diagnosis of synchronous pancreatic cancer and intrahepatic cholangiocarcinoma: A case report.

Item

http://www.wikidata.org/entity/Q49487531

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Utility of KRAS mutational ana ...... angiocarcinoma: A case report.

@en

Utility of KRAS mutational ana ...... angiocarcinoma: A case report.

@nl

type

Item

label

Utility of KRAS mutational ana ...... angiocarcinoma: A case report.

@en

Utility of KRAS mutational ana ...... angiocarcinoma: A case report.

@nl

prefLabel

Utility of KRAS mutational ana ...... angiocarcinoma: A case report.

@en

Utility of KRAS mutational ana ...... angiocarcinoma: A case report.

@nl

P1476

Utility of KRAS mutational ana ...... langiocarcinoma: A case report

@en

P2093

Hiroko Yamagishi

http://www.w3.org/2001/XMLSchema#string

Kazuaki Imada

http://www.w3.org/2001/XMLSchema#string

Toshihiko Masui

http://www.w3.org/2001/XMLSchema#string

Yuto Kimura

http://www.w3.org/2001/XMLSchema#string

Yuzo Kodama

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic profiling of intrahepatic cholangiocarcinoma and its clinical implication in targeted therapy

Targeting RAS signalling pathways in cancer therapy

Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes.

KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas.

KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas.

Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.

Simultaneous identification of 36 mutations in KRAS codons 61 and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kit.

Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms.

Roles for KRAS in pancreatic tumor development and progression.

The CARE guidelines: consensus-based clinical case report guideline development.

P304

e9217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1097/MD.0000000000009217

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yuji Eso

Hiroshi Seno

Norimitsu Uza

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29390348

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

5815760

http://www.w3.org/2001/XMLSchema#string